XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit).
Total
Balances at the beginning at Dec. 31, 2022 $ 20 $ 131,001 $ (9,621) $ 121,400
Balances at the beginning (in shares) at Dec. 31, 2022 20,252,677      
Increase (Decrease) in Stockholders' Equity        
Stock-based compensation   2,023   2,023
Exercise of common stock options and vesting of performance and restricted stock units (in shares) 107,388      
Sale of common stock from follow-on public offering, net of offering expenses $ 3 34,622   34,625
Sale of common stock from follow-on public offering, net of offering expenses (in shares) 2,875,000      
Net loss for the period     (1,886) (1,886)
Balances at the end at Mar. 31, 2023 $ 23 167,646 (11,507) 156,162
Balances at the end (in shares) at Mar. 31, 2023 23,235,065      
Balances at the beginning at Dec. 31, 2023 $ 24 174,724 18,894 193,642
Balances at the beginning (in shares) at Dec. 31, 2023 23,600,584      
Increase (Decrease) in Stockholders' Equity        
Stock-based compensation   2,039   2,039
Exercise of common stock options and vesting of performance and restricted stock units   1   1
Exercise of common stock options and vesting of performance and restricted stock units (in shares) 161,313      
Net loss for the period     (2,209) (2,209)
Balances at the end at Mar. 31, 2024 $ 24 $ 176,764 $ 16,685 $ 193,473
Balances at the end (in shares) at Mar. 31, 2024 23,761,897